ArticleCancers2021

Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer "PantHER".

Niamh M Keegan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.